The influence of selective A1 and A2A receptor antagonists on the antidepressant‐like activity of moclobemide, venlafaxine and bupropion in mice. (25th June 2018)
- Record Type:
- Journal Article
- Title:
- The influence of selective A1 and A2A receptor antagonists on the antidepressant‐like activity of moclobemide, venlafaxine and bupropion in mice. (25th June 2018)
- Main Title:
- The influence of selective A1 and A2A receptor antagonists on the antidepressant‐like activity of moclobemide, venlafaxine and bupropion in mice
- Authors:
- Bogatko, Karolina
Poleszak, Ewa
Szopa, Aleksandra
Wyska, Elżbieta
Wlaź, Piotr
Świąder, Katarzyna
Wlaź, Aleksandra
Doboszewska, Urszula
Rojek, Karol
Serefko, Anna - Abstract:
- Abstract: Objective: The main goal of our study was to investigate whether a selective antagonism of the adenosine A1 or A2A receptors is able to enhance the antidepressant activity of commonly prescribed drugs. Materials and methods: All experiments were carried out on male Albino Swiss mice. The forced swim test and the tail suspension test were used to evaluate the antidepressant‐like potential. Drug concentrations in animals' serum and brains were measured by high‐performance liquid chromatography. Key findings: The antidepressant potential of moclobemide (1.5 mg/kg), venlafaxine (1 mg/kg) and bupropion (10 mg/kg) was enhanced by a co‐administration with 3, 7‐dimethyl‐1‐propargylxanthine (DMPX; an antagonist of adenosine A2A receptors; 3 mg/kg) or 8‐cyclopentyl‐1, 3‐dipropylxanthine (an antagonist of adenosine A1 receptors; 1 mg/kg). However, significant interactions between the tested substances were detected only in the experiments with DMPX. The nature of the observed interplays is rather pharmacodynamic than pharmacokinetic, because neither serum nor brain concentrations of the used drugs were significantly increased. Conclusions: Blockage of the adenosine receptors (particularly the A2A subtypes) could be considered in future as a novel, promising part of the combined antidepressant therapy. However, further studies on this subject are needed.
- Is Part Of:
- Journal of pharmacy and pharmacology. Volume 70:Number 9(2018)
- Journal:
- Journal of pharmacy and pharmacology
- Issue:
- Volume 70:Number 9(2018)
- Issue Display:
- Volume 70, Issue 9 (2018)
- Year:
- 2018
- Volume:
- 70
- Issue:
- 9
- Issue Sort Value:
- 2018-0070-0009-0000
- Page Start:
- 1200
- Page End:
- 1208
- Publication Date:
- 2018-06-25
- Subjects:
- bupropion -- DMPX -- DPCPX -- moclobemide -- venlafaxine
Pharmacy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- https://academic.oup.com/jpp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2042-7158 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.ingentaconnect.com/content/rpsgb/jpp ↗ - DOI:
- 10.1111/jphp.12954 ↗
- Languages:
- English
- ISSNs:
- 0022-3573
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5034.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7127.xml